Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chinese, U.S. Researchers Isolate Ovarian Cancer Bio-Markers

This article was originally published in PharmAsia News

Executive Summary

Researchers from mainland China and Taiwan working with U.S. colleagues say they were able to identify bio-markers in ovarian tumors that might lead to improvements in current cancer treatment. Previous work had identified cancer stem cells in several tumor types, including brain and breast cancer, but the multinational research team has now located them in ovarian tumor tissues. Two bio-markers, CD44 and CD117, were identified as specific only to ovarian cancer cells. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068895

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel